tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Mesoblast options imply 11.6% move in share price post-earnings
PremiumThe FlyMesoblast options imply 11.6% move in share price post-earnings
21h ago
Mesoblast Limited Announces Webcast on Fiscal Year 2025 Financial Results
Premium
Company Announcements
Mesoblast Limited Announces Webcast on Fiscal Year 2025 Financial Results
2d ago
State Street Global Advisors Ceases Substantial Holding in Mesoblast
Premium
Company Announcements
State Street Global Advisors Ceases Substantial Holding in Mesoblast
4d ago
Mesoblast reports Q1 Ryoncil gross revenue $13.2M
PremiumThe FlyMesoblast reports Q1 Ryoncil gross revenue $13.2M
1M ago
Mesoblast Reports Successful Launch of Ryoncil® and Expands Pipeline Efforts
Premium
Company Announcements
Mesoblast Reports Successful Launch of Ryoncil® and Expands Pipeline Efforts
1M ago
JPMorgan Acquires 5% Stake in Mesoblast Limited
Premium
Company Announcements
JPMorgan Acquires 5% Stake in Mesoblast Limited
1M ago
Buy Rating for Mesoblast: FDA Alignment and Promising Revascor Data Drive Optimism
PremiumRatingsBuy Rating for Mesoblast: FDA Alignment and Promising Revascor Data Drive Optimism
2M ago
Mesoblast Aligns with FDA for Revascor Biologics License Application
Premium
Company Announcements
Mesoblast Aligns with FDA for Revascor Biologics License Application
2M ago
JPMorgan Chase & Co. Reduces Stake in Mesoblast Limited
Premium
Company Announcements
JPMorgan Chase & Co. Reduces Stake in Mesoblast Limited
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100